Education

1975-1979 Bachelor of Arts, Bowdoin College, Brunswick, Maine

1979-1983 Doctor of Medicine, New York University School of Medicine, New York, New York

Postdoctoral Training

1983-1984 Intern-in-Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina

1984-1985 Junior Assistant Resident, Department of Medicine, Duke University Medical Center, Durham, North Carolina

1985-1986 Senior Assistant Resident, Department of Medicine, Duke University Medical Center, Durham, North Carolina

1986-1989 Hematology/Oncology Fellowship, Division of Hematology/Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina

Certification/Board Eligibility

Hematology 1990
Medical Oncology 1989
Internal Medicine 1986

Professional Societies

2007 American Society of Breast Diseases
1994 Northern New England Clinical Oncology Society
1993 New Hampshire Medical Society
1992 American Society of Clinical Oncology
1991 American Society of Hematology
1991 American Federation for Clinical Research
1989 Member, American College of Physicians
1985 Associate Member, American College of Physicians

Publications

For a complete list of Peter Kaufman's publications, please visit PubMed.

1. Kaufman PA, Wildiers H, Freyer G, Kemeny M, Gonçalves A, Jerusalem G, Stopeck A, Vrindavanam N, Dalenc F, Nanayakkara N, Wu B, Pickett CA. Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer.  Clin Breast Cancer. 2019 Feb;19(1):47-57.  PMID: 30420181.

2. Kathleen Doyle Lyons, Martha L Bruce, Jay G Hull, Peter A Kaufman, Zhongze Li, Diane M Stearns, Frederick Lansigan, Mary Chamberlin, Alexander Fuld, Stephen J Bartels, Jessica Whipple, Marie A Bakitas, Mark T Hegel. Health Through Activity: Initial Evaluation of an In-Home Intervention for Older Adults With Cancer.  Occup Ther Sep/Oct 2019 PMID: 31484031 PMCID: PMC6813498 DOI: 10.5014/ajot.2019.035022

3. Peter A Kaufman, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Eva-Maria Grischke, Valerie Andre, Clemens Stoffregen , Sarah Shekarriz, Gregory L Price, Gebra Cuyun Carter, George W Sledge Jr . Health-Related Quality of Life in MONARCH 2: Abemaciclib Plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy. Oncologist. 2019 Oct 24 PMID: 31649135 PMCID: PMC7011625   DOI: 10.1634/theoncologist.2019-0551

4. Javier Cortes, MD, PhD; Jose Manuel Perez-García, MD, PhD; Antonio Llombart-Cussac, MD; Giuseppe Curigliano, MD, PhD; Nagi S. El Saghir, MD; Fatima Cardoso, MD; Carlos H. Barrios, MD; Shama Wagle, MRPharmS; Javier Roman, MD; Nadia Harbeck, MD; Alexandru Eniu, MD, PhD; Peter A. Kaufman, MD;Josep Tabernero, MD, PhD2; Laura García-Estévez, MD; Peter Schmid, FRCP, MD, PhD; Joaquín Arribas, PhD. Enhancing Global Access to Cancer Medicines. A Cancer Journal for Clinicians. Feb. 2020

5. Peter A Kaufman , Masakazu Toi , Patrick Neven , Joohyuk Sohn , Eva-Maria Grischke , Valerie Andre , Clemens Stoffregen , Sarah Shekarriz, Gregory L Price , Gebra Cuyun Carter , George W Sledge Jr.  Health-Related Quality of Life in MONARCH 2: Abemaciclib Plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy. Oncologist. Feb 2020 PMID: 32043763 DOI: 10.1634/theoncologist.2019-0551

6. Debu Tripathy, Adam Brufsky, Melody Cobleigh, Mohammad Jahanzeb, Peter A Kaufman, Ginny Mason, Joyce O'Shaughnessy, Hope S Rugo, Sandra M Swain, Denise A Yardley, Laura Chu, Haocheng Li, Vincent Antao, Sara A Hurvitz. De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival From the SystHERs Registry. Oncologist, 25 (2), e214-e222. Feb 2020 PMID: 32043771, DOI: 10.1634/theoncologist.2019-0446